Related Experiment Video
Updated: Feb 18, 2026

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
3.1K
Mumps in Poland in 2015
1National Institute of Public Health – National Institute of Hygiene in Warsaw, Department of Epidemiology
Przeglad Epidemiologiczny
|November 29, 2017
Summary
Mandatory mumps vaccination in Poland significantly reduced cases by 20.4% since 2009. High vaccination coverage, reaching 96.3% in 3-year-olds, is expected to further decrease mumps incidence.
Area of Science:
- Epidemiology
- Immunization
- Public Health
Background:
- Mumps vaccination became mandatory in Poland in 2003, utilizing a two-dose MMR vaccine schedule.
- Despite a decade-long decline in mumps incidence due to vaccinations, the disease remains prevalent among children.
Purpose of the Study:
- To evaluate the epidemiological status of mumps in Poland during 2015.
- To assess mumps vaccination coverage within the Polish population and compare it with previous years.
Main Methods:
- Descriptive analysis utilizing data from Poland's mandatory surveillance system and annual bulletins on infectious diseases and vaccinations.
- Mumps case classification followed European Union surveillance criteria.
- Data from the National Immunisation Programme for 2015 were also incorporated.
Main Results:
- Poland registered 2,208 mumps cases in 2015, with an incidence of 5.7 per 100,000 population, a decrease from 2014 and the 2009-2014 median.
- The highest incidence was observed in 5-year-old children (48.3 per 100,000), with higher rates in men than women.
- Vaccination coverage for 3-year-olds in 2015 was 96.3%, a slight decrease from the previous year.
Conclusions:
- Consistent implementation of the National Immunisation Programme has led to a substantial reduction in registered mumps cases.
- High vaccination coverage is anticipated to result in a continued decrease in mumps incidence.
Related Concept Videos
Vaccinations
52.0K
Overview
52.0K
Single Nucleotide Polymorphisms-SNPs
18.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K
Zygotic Development And Stem Cell Formation
6.9K
The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
6.9K

